OP-178 Galectin-3 Levels in Hypertrophic Cardiomyopathy and the Relationship with Left Ventricular Mass Index and Function




Background


In hypertrophic cardiomyopathy (HCM) cardiac fibrosis is an important contributor of adverse left ventricular (LV) remodelling and arrhythmias. Galectin-3 (Gal-3) is a novel marker of cardiac fibrosis and inflamation. In this study we investigated the levels of Gal-3 in patients with HCM and control subjects and assessed the relationship between Gal-3 levels and echocardiographic indices using strain echocardiography.




Methods


Forty patients with HCM and 35 healthy control subjects were enrolled. Global LV strain and strain rates, LV mass index (LVMI) of all subjects were assessed by echocardiography. Galectin-3 levels of all subjects were measured.




Methods


Forty patients with HCM and 35 healthy control subjects were enrolled. Global LV strain and strain rates, LV mass index (LVMI) of all subjects were assessed by echocardiography. Galectin-3 levels of all subjects were measured.

Only gold members can continue reading. Log In or Register to continue

Related posts:

  1. OP-001 An Under-estimated Complication ff Atrial Fibrillation Ablation: Gastroparesis
  2. OP-038 Reduction of Eosinophil Percentage may Predict the Mortality from Acute Coronary Syndromes
  3. OP-065 Increased Platelet-to-Lymphocyte Ratio is Related to Slow Coronary Flow
  4. OP-100 Pulmonary Function after Transcatheter Aortic Valve Implantation in Patients with High Risk Aortic Stenosis

Stay updated, free articles. Join our Telegram channel
Tags:
Nov 30, 2016 | Posted by in CARDIOLOGY | Comments Off on OP-178 Galectin-3 Levels in Hypertrophic Cardiomyopathy and the Relationship with Left Ventricular Mass Index and Function

Full access? Get Clinical Tree
Get Clinical Tree app for offline access